Previous Article | Next Article 
Journal of Clinical Microbiology, November 2008, p. 3802-3803, Vol. 46, No. 11
0095-1137/08/$08.00+0 doi:10.1128/JCM.00128-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
Molecular Typing of Treponema pallidum Clinical Strains from Lisbon, Portugal
C. Florindo,1
V. Reigado,1
J. P. Gomes,1
J. Azevedo,2
I. Santo,2 and
M. J. Borrego1*
Department of Infectious Diseases, National Institute of Health, Av. Padre Cruz, Lisbon 1649-016, Portugal,1
STD Clinics, Lapa Health Centre, R. São Ciro, Lisbon 1200-831, Portugal2
Received 22 January 2008/
Returned for modification 1 August 2008/
Accepted 15 August 2008

ABSTRACT
A molecular system was used to subtype Portuguese
Treponema pallidum clinical strains isolated from both skin lesions and
blood. The study with this system constitutes the first typing
study in a European country. Three
T. pallidum subtypes were
found: subtypes 14a (50%), 14d (45.2%), and 14f (4.8%). Further
studies are needed to better characterize the isolates involved
in syphilis outbreaks.

TEXT
Syphilis, caused by the spirochete
Treponema pallidum subsp.
pallidum, is a multistage disease with a wide spectrum of clinical
manifestations (
8). Of particular relevance to public health
is the recognition that syphilis increases the risk of transmission
and acquisition of the human immunodeficiency virus (
6). Until
the end of the 20th century, the in vitro noncultivable condition
of
T. pallidum, allied with the high GC content of major portions
of its genome (
5), prevented the success of any strategy for
the typing of
T. pallidum clinical isolates. In 1998, Pillay
et al. (
13) made a very important step toward obtaining an understanding
of the molecular epidemiology of
T. pallidum by developing the
only existing method for the genotyping of this pathogen. The
method is based on the intrastrain variability of the acidic
repeat protein gene (
arp) and the
Treponema pallidum repeat
gene (
tpr). To date, the laboriousness and low sensitivity of
this procedure have limited its application to only five published
studies (
11,
13-
15,
17), focused mainly in two countries, South
Africa and the United States. Consequently, there are only 288
typed
T. pallidum strains worldwide (
11,
13-
15,
17), which is
a strikingly small number, considering the predicted syphilis
incidence rate (
18). In Portugal, early and congenital syphilis
require mandatory notification (
4); nonetheless, as in the rest
of Europe, there is a complete lack of awareness of the diversity
of the circulating
T. pallidum strains. Here we report the results
of a pioneer study in which we used the recent subtyping system
developed by Pillay et al. at the Centers for Disease Control
and Prevention (
13) in order to identify and differentiate Portuguese
T. pallidum isolates.
Four hundred sixteen individuals (104 women and 312 men) suspected of having early syphilis (on the basis of clinical data and serology), most of whom were attending the major Portuguese sexually transmitted disease clinic (located at the Lapa Health Centre in Lisbon, Portugal), were evaluated for T. pallidum infection between 2004 and 2007. T. pallidum DNA was extracted from skin lesions or blood samples by using a QIAamp DNA mini kit (Qiagen, Valencia, CA), according to the manufacturer's instructions. T. pallidum was detected in 86 specimens (35 primary and 7 secondary lesions and 44 blood samples) by using a commercially available real-time PCR assay (Sacace, Caserta, Italy) that targets the gene coding for a recognized T. pallidum surface antigen, the 39-kDa basic membrane protein (bmp; locus TP1016 relative to the sequence of T. pallidum strain Nichols, GenBank accession number NC_000919 [3, 5]). The results for all real-time PCR-positive specimens were further confirmed by the use of a conventional PCR that targets a different T. pallidum gene, the DNA polymerase I (polA; locus TP0105 relative to the sequence of T. pallidum strain Nichols, GenBank accession number NC_000919 [5, 9, 10]). The polA 377-bp product was amplified as described by Liu et al. (9). No dark-field microscopy was conducted with the skin lesion exudates.
For molecular typing, the variable region of 60-bp repeats within the arp gene and the tprE, trpG, and trpJ genes were amplified and analyzed as described previously (11, 13), but by using a modified protocol. Briefly, 3 U of Bio-X-Act DNA polymerase (Bioline, London, United Kingdom) was used for the arp and tpr PCR mixtures. For both PCRs, the termocycling profiles consisted of an initial denaturation step at 94°C for 5 min, followed by 40 cycles (for arp) or 35 cycles (for tpr) at 94°C for 30 s and 62°C (for arp) or 60°C (for tpr) for 30 s and a final elongation step at 70°C for 2 min. The final extension step consisted of 10 min at 70°C. The number of arp gene tandem repeats was estimated as described previously (11) by using the O'range 100-bp DNA ladder (Peqlab, Erlangen, Germany).
By combining the results for the arp repeats and the tpr restriction pattern, we were able to fully genotype 64.3% (27/42) of the T. pallidum skin lesion isolates (23 from patients with primary syphilis and 4 from patients with secondary syphilis) and 34.1% (15/44) of the T. pallidum blood sample isolates. This poor proficiency, which has also been described by other authors (14), is largely related to the low rate of success of the arp gene PCR assay. The lower efficiency observed for the blood specimens is similar to that previously reported by Sutton et al. (17) for this type of biological sample. In fact, the treponemal load was probably higher in skin lesions than in blood samples (despite the capacity of the bacteria to readily disseminate into the bloodstream [8, 16]), and PCR-inhibitory substances are more likely to be present in blood than in ulcer exudates (1). Despite these difficulties, the use of blood specimens seems to be a valuable tool for studies of the molecular epidemiology T. pallidum because it allows expansion of the typing of the organism to isolates recovered during the various stages of the disease. Moreover, it could shed light on the invasiveness of the different genotypes, which will contribute to a better understanding of the pathology of T. pallidum.
Overall, 48.8% (42/86) of the T. pallidum-positive specimens were typed (including six strains from three couples). This allowed the identification of subtypes 14a, 14d, and 14f (Fig. 1) and revealed a low level of genetic diversity. The predominant subtype, subtype 14a, was identified in 21 (50%) specimens, followed by subtypes 14d and 14f, which were found in 19 (45.2%) and 2 (4.8%) specimens, respectively. Subtypes 14a and 14d were also identified in other studies (11, 13, 14, 17), namely, in studies conducted in South Africa, where they were shown to be predominant in cerebrospinal fluid and genital ulcer specimens, respectively. To our knowledge, our work provides the first evidence of the existence of subtype 14f outside the United States, where it is the most common subtype (15, 17).
Curiously, the
T. pallidum isolates from two of the three couples
enrolled in the typing study presented discordant results by
genotyping and were found to be of subtypes 14a and 14d. Possible
reasons for this discrepancy (associated with
tpr restriction
pattern) may be related to (i) the existence of other sexual
partners, (ii) the presence of a mixed infection, and (iii)
genetic variation of the
tpr gene subfamily II during host passage
that results in different restriction patterns. This last hypothesis
is supported by the findings of several other studies (
2,
7,
12) that provided evidence of
tprK sequence diversification
during
T. pallidum infection and host transmission. As recommended
by Pillay et al. (
14) and reinforced by our results, further
studies will be necessary to evaluate the stability of the
T. pallidum tpr subtypes within individual sexual networks.
Globally, genotyping of T. pallidum strains will contribute to the characterization of syphilis outbreaks, the evaluation of genotype invasiveness and virulence, differentiation between relapse and reinfection episodes, and knowledge about the distribution of bacterial types.

ACKNOWLEDGMENTS
This work was partly supported by Comissão de Fomento
da Investigação em Cuidados de Saúde (grant
124/2007).

FOOTNOTES
* Corresponding author. Mailing address: Department of Infectious Diseases, Instituto Nacional de Saúde Dr. Ricardo Jorge, Av. Padre Cruz, Lisbon 1649-016, Portugal. Phone: 351 217519241. Fax: 351 217526400. E-mail:
m.jose.borrego{at}insa.min-saude.pt 
Published ahead of print on 27 August 2008. 

REFERENCES
1 - Al-Soud, W. A., and P. Rådström. 2001. Purification and characterization of PCR-inhibitory components in blood cells. J. Clin. Microbiol. 39:485-493.[Abstract/Free Full Text]
2 - Centurion-Lara, A., R. E. LaFond, K. Hevner, C. Godernes, B. J. Molini, W. C. Van Voorhis, and S. A. Lukehart. 2004. Gene conversion: a mechanism for generation of heterogeneity in the tprK gene of Treponema pallidum during infection. Mol. Microbiol. 52:1579-1596.[CrossRef][Medline]
3 - Dallas, W. S., P. H. Ray, J. Leong, C. D. Benedict, L. V. Stamm and P. J. Bassford, Jr. 1987. Identification and purification of a recombinant Treponema pallidum basic membrane protein antigen expressed in Escherichia coli. Infect. Immun. 55:1106-1115.[Abstract/Free Full Text]
4 - Fenton, K. A., and C. M. Lowndes. 2004. Recent trends in the epidemiology of sexually transmitted infections in the European Union. Sex. Transm. Infect. 80:255-263.[Abstract/Free Full Text]
5 - Fraser, C. M., S. J. Norris, G. M. Weinstock, O. White, G. G. Sutton, R. Dodson, M. Gwinn, E. K. Hickey, R. Clayton, K. A. Ketchum, E. Sodergren, J. M. Hardham, M. P. McLeod, S. Salzberg, J. Peterson, H. Khalak, D. Richardson, J. K. Howell, M. Chidambaram, T. Utterback, L. McDonald, P. Artiach, C. Bowman, M. D. Cotton, C. Fujii, S. Garland, B. Hatch, K. Horst, K. Roberts, M. Sandusky, J. Weidman, H. O. Smith, and J. C. Venter. 1998. Complete genome sequence of Treponema pallidum, the syphilis spirochete. Science 281:375-388.[Abstract/Free Full Text]
6 - Greenblatt, R. M., S. A. Lukehart, F. A. Plummer, T. C. Quinn, C. W. Critchlow, R. L. Ashley, L. J. D'Costa, J. O. Ndinya-Achola, L. Corey, and A. R. Ronald. 1988. Genital ulceration as a risk factor for human immunodeficiency virus infection. AIDS 2:47-50.[Medline]
7 - LaFond, R. E., A. Centurion-Lara, C. Godornes, A. M. Rompalo, W. C. Van Voorhis, and S. A. Lukehart. 2003. Sequence diversity of Treponema pallidum subsp. pallidum tprK in human syphilis lesions and rabbit-propagated isolates. J. Bacteriol. 185:6262-6268.[Abstract/Free Full Text]
8 - LaFond, R. E., and S. A. Lukehart. 2006. Biological basis for syphilis. Clin. Microbiol. Rev. 19:29-49.[Abstract/Free Full Text]
9 - Liu, H., B. Rodes, C. Y. Chen, and B. Steiner. 2001. New tests for syphilis: rational design of a PCR method for detection of Treponema pallidum in clinical specimens using unique regions of the DNA polymerase I gene. J. Clin. Microbiol. 39:1941-1946.[Abstract/Free Full Text]
10 - Marfin, A. A., H. Liu, M. Y. Sutton, B. Steiner, A. Pillay, and L. E. Markowitz. 2001. Amplification of the DNA polymerase I gene of Treponema pallidum from whole blood of persons with syphilis. Diagn. Microbiol. Infect. Dis. 40:163-166.[CrossRef][Medline]
11 - Molepo, J., A. Pillay, B. Weber, S. A. Morse, and A. A. Hoosen. 2007. Molecular typing of Treponema pallidum strains from patients with neurosyphilis in Pretoria, South Africa. Sex. Transm. Infect. 83:189-192.[Abstract/Free Full Text]
12 - Myint, M., H. Bashiri, R. D. Harrington, and C. M. Marra. 2004. Relapse of secondary syphilis after benzathine penicillin G: molecular analysis. Sex. Transm. Dis. 31:196-199.[Medline]
13 - Pillay, A., H. Liu, C. Y. Chen, B. Holloway, A. W. Sturm, B. Steiner, and S. A. Morse. 1998. Molecular subtyping of Treponema pallidum subspecies pallidum. Sex. Transm. Dis. 25:408-414.[Medline]
14 - Pillay, A., H. Liu, S. Ebrahim, C. Y. Chen, W. Lai, G. Fehler, R. C. Ballard, B. Steiner, A. W. Sturm, and S. A. Morse. 2002. Molecular typing of Treponema pallidum in South Africa: cross-sectional studies. J. Clin. Microbiol. 40:256-258.[Abstract/Free Full Text]
15 - Pope, V., K. Fox, H. Liu, A. A. Marfin, P. Leone, A. C. Seña, J. Chapin, M. B. Fears, and L. Markowitz. 2005. Molecular subtyping of Treponema pallidum from North and South Carolina. J. Clin. Microbiol. 43:3743-3746.[Abstract/Free Full Text]
16 - Salazar, J. C., A. Rathi, N. L. Michael, J. D. Radolf, and L. L. Jagodzinski. 2007. Assessment of the kinetics of Treponema pallidum dissemination into blood and tissues in experimental syphilis by real-time quantitative PCR. Infect. Immun. 75:2954-2958.[Abstract/Free Full Text]
17 - Sutton, M. Y., H. Liu, B. Steiner, A. Pillay, T. Mickey, L. Finelli, S. Morse, L. E. Markowitz, and M. E. St. Louis. 2001. Molecular subtyping of Treponema pallidum in an Arizona County with increasing syphilis morbidity: use of specimens from ulcers and blood. J. Infect. Dis. 183:1601-1606.[CrossRef][Medline]
18 - World Health Organization. 2001. Global prevalence and incidence of selected curable sexually transmitted infections: overview and estimates. World Health Organization, Geneva, Switzerland. http://who.int/docstore/hiv/GRSTI/.
Journal of Clinical Microbiology, November 2008, p. 3802-3803, Vol. 46, No. 11
0095-1137/08/$08.00+0 doi:10.1128/JCM.00128-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Cole, M J, Chisholm, S A, Palmer, H M, Wallace, L A, Ison, C A
(2009). Molecular epidemiology of syphilis in Scotland. Sex. Transm. Infect.
85: 447-451
[Abstract]
[Full Text]
-
Castro, R., Prieto, E., Aguas, M. J., Manata, M. J., Botas, J., Martins Pereira, F.
(2009). Molecular Subtyping of Treponema pallidum subsp. pallidum in Lisbon, Portugal. J. Clin. Microbiol.
47: 2510-2512
[Abstract]
[Full Text]